WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

California startup Protuoso raises $9.5m for “mix-and-match” drug platform - Pharmaceutical Technology

The US biotech’s technology integrates multiple protein modalities to simultaneously target a variety of disease mechanisms.

Raccontata daendpoints.newspharmaceutical-technology.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
pharmaceutical-technology.comStai leggendo7 h fa

California startup Protuoso raises $9.5m for “mix-and-match” drug platform - Pharmaceutical Technology

The US biotech’s technology integrates multiple protein modalities to simultaneously target a variety of disease mechanisms.

originale
endpoints.news1 g fa

Exclusive: Protuoso gets $9.5M to build the next hub-and-spoke antibody developer

Variations on the hub-and-spoke model have blossomed in the drug development industry over the past few years — and a new antibody hub is entering the fray.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 26 maggio 2026·endpoints.news

    Exclusive: Protuoso gets $9.5M to build the next hub-and-spoke antibody developer

    Variations on the hub-and-spoke model have blossomed in the drug development industry over the past few years — and a new antibody hub is entering the fray.

  2. mercoledì 27 maggio 2026·pharmaceutical-technology.com

    California startup Protuoso raises $9.5m for “mix-and-match” drug platform - Pharmaceutical Technology

    The US biotech’s technology integrates multiple protein modalities to simultaneously target a variety of disease mechanisms.